Andra AP fonden increased its position in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) by 104.1% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 836,500 shares of the real estate investment trust’s stock after purchasing an additional 426,700 shares during the period. Andra AP fonden owned 0.12% of Healthpeak Properties worth $14,647,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in DOC. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Healthpeak Properties by 584.6% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 9,218,848 shares of the real estate investment trust’s stock valued at $186,405,000 after buying an additional 7,872,150 shares during the last quarter. Nuveen LLC purchased a new stake in Healthpeak Properties in the 1st quarter valued at $124,113,000. Invesco Ltd. boosted its stake in Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust’s stock worth $467,311,000 after purchasing an additional 3,967,830 shares during the period. Nordea Investment Management AB grew its position in Healthpeak Properties by 7,444.0% during the 2nd quarter. Nordea Investment Management AB now owns 3,923,205 shares of the real estate investment trust’s stock worth $67,871,000 after purchasing an additional 3,871,201 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Healthpeak Properties by 57.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 6,764,854 shares of the real estate investment trust’s stock worth $136,785,000 after purchasing an additional 2,477,307 shares during the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.
Analyst Ratings Changes
Several brokerages have recently weighed in on DOC. Scotiabank downgraded shares of Healthpeak Properties from a “sector outperform” rating to a “sector perform” rating and decreased their target price for the stock from $21.00 to $19.00 in a research note on Tuesday, July 29th. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 27th. Evercore ISI set a $22.00 price objective on Healthpeak Properties in a research report on Monday, September 15th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a report on Wednesday, August 20th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Healthpeak Properties in a research note on Wednesday, October 8th. Seven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $20.91.
Healthpeak Properties Trading Down 1.6%
NYSE:DOC opened at $17.58 on Friday. Healthpeak Properties, Inc. has a 1 year low of $16.63 and a 1 year high of $23.05. The company has a debt-to-equity ratio of 1.11, a quick ratio of 1.28 and a current ratio of 1.22. The stock has a fifty day moving average price of $18.39 and a two-hundred day moving average price of $17.86. The stock has a market capitalization of $12.22 billion, a price-to-earnings ratio of -351.53, a PEG ratio of 3.84 and a beta of 1.10.
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.01. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The business had revenue of $705.87 million for the quarter, compared to analysts’ expectations of $681.65 million. During the same period in the prior year, the company posted $0.45 EPS. The business’s revenue for the quarter was up .8% on a year-over-year basis. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current fiscal year.
Healthpeak Properties Announces Dividend
The business also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a dividend yield of 6.9%. The ex-dividend date is Friday, December 19th. Healthpeak Properties’s dividend payout ratio (DPR) is presently -2,440.00%.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Read More
- Five stocks we like better than Healthpeak Properties
- When to Sell a Stock for Profit or Loss
- CAVA Stock Looking for Direction After Earnings Miss
- With Risk Tolerance, One Size Does Not Fit All
- 3 Small AI Stocks Ready to Explode (All Under $20)
- What is the MACD Indicator and How to Use it in Your Trading
- After 16% Fall, Analysts Eye a Big Recovery in Meta Platforms
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
